Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Identificação de fatores relacionados ao grau de incapacidade de pacientes com hanseníase no município de Cuiabá-MT.

Prata FRM, Pankowski GS, Campos ITD, et al. COORTE - REVISTA CIENTIFICA DO HOSPITAL SANTA ROSA. COORTE - Revista Científica do Hospital Santa Rosa. 2023;
Download PDF
Publication

Efeitos do estigma na permanência da Hanseníase

Alvarenga AVM, Da Silva GR, Vale DHA. South Florida Publishing LLC. Observatório De La Economía Latinoamericana. 2023; 21 (8) : 9018-9037.
Download PDF
Publication

Borderline type leprosy with variation of clinical manifestations and histopathology: two case reports

Karmila G. A. A. D, Rusyati L. M. M, Saputra H, et al. Bali Medical Journal. 2023; 12 (3) : 2440-2445.
Download PDF
Publication

Increscent journey of anti-leprosy drug development.

Gautam S, Sharma D, Singh S, et al. Current Science. 2023; 125 (3) : 253-267.
Download PDF
Publication

Perfil epidemiológico da hanseníase na capital amazonense durante o período de 2018 a 2022

Watanuki AP, De Souza CF, Gomes MVL, et al. Universidade Paranaense. Arquivos de Ciências da Saúde da UNIPAR. 2023; 27 (8) : 4642-4654.
Download PDF
Publication

Perfil epidemiológico da hanseníase em crianças e adolescentes no estado do acre – amazônia ocidental, brasil – no período de 2018 a 2022

Ferreira Cavalcante N, Rezende Santos A, Silva Lima da Costa R. RECIMA21 - Revista Cientifica Multidisciplinar. RECIMA21 - Revista Científica Multidisciplinar. 2023; 4 (8) : 1-12.
Download PDF
Publication

Perfil epidemiológico dos casos de hanseníase em um estado do nordeste brasileiro de 2018 a 2022

Freire LDV, Melo FDF, Lima SADO, et al. Universidade Paranaense. Arquivos de Ciências da Saúde da UNIPAR. 2023; 27 (8) : 4729-4741.
Download PDF
Publication

Cuidados de Enfermagem à Pacientes Idosos com Hanseníase na Atenção Primária de Saúde: Uma Revisão

Izaquiel Marinho J, Lima de Andrade L. Even3. IV Congresso Internacional de Saúde Única (Interface Mundial). 2022;
Download PDF
Publication

Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction.

Alfredo M, Schmitt J, Miola A, et al. Anais brasileiros de dermatologia. 2023;
Download PDF
Publication

Role of cytopathology in diagnosing phaeohyphomycosis masquerading as nerve abscess in a lepromatous leprosy patient: A case report.

Yadav S, Chandana B, Panwar H, et al. International journal of surgery case reports. 2023;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 140
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD